None listed
Conditions
Brief summary
IVD insertion is the most common invasive healthcare procedure with approximately 14 million IVDs used in Australia each year. IVDs alone are inadequate to deliver most therapy and require connection to an administration set. These IVD administration sets (AS) refer to infusion systems comprised of some or all of: tubing, fluid containers, pressure monitoring transducers, blood sampling ports, measuring burettes and extension tubing. IVDs and their AS break the natural defence barrier of the skin, and are the single most important cause of healthcare acquired blood stream infection (BSI). Most IVD's are replaced every 3 -4 days , however preliminary research suggests routine replacement of AS every 4 days costs Australia about $1 billion annually, and some studies suggest 7 day use would reduce costs with no threat to patient safety.
Interventions
Patients in this study have intravascular devices (IVDs) used in medical, surgical, intensive care, oncology and haematology units, and include adult and paediatric patients. Patients will have their administration set replaced every 7 days. This will continue for the course of their intravenous (IV) therapy.
Sponsors
Griffith University
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
0 to No maximum
Healthy volunteers
No
Inclusion criteria
1. Informed written consent or waived consent (as per approving HREC) 2. Central venous or peripheral arterial IVD in situ. 3. IVD and AS have been insitu for equal to or more than 24 hours 4. IVD scheduled/expected use equal to or more than 7 days
Exclusion criteria
Current bloodstream infection (within the previous 48 hours) Planned removal of device less than or equal to 24 hours IVD in situ >96 hours Original AS already routinely replaced
Outcome results
None listed